The company released its third quarter results Nov. 6.
Three notes on the company’s third quarter performance:
1. Alphatec saw a 24% increase in surgical volume and a 6% increase in average revenue per procedure.
2. The company brought in $150 million in capital to increase investment in implants and instrument sets.
3. The company reported an ending cash balance of $123 million.
